ACTRN12622001365752尚未招募未知
An open-label, uncontrolled acceptability trial of a self-guided, online parenting program (‘PiP-Ed’) to support parents of adolescents who refuse school in the context of anxiety and/or depression.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Parents and/or guardians of adolescents aged 12-18 years who:
- •- are refusing school due to anxiety and/or depression
- •- live in Australia
- •- are proficient in English
- •- have regular internet access.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluating the acceptability of a therapist-assisted, online parenting program (‘PiP-Education’) to support parents of adolescents who refuse school in the context of anxiety and/or depression.ACTRN12622000977774Monash University14
进行中（未招募）
1 期
Study to evaluate the tolerability of a combination therapy consisting of GAD-alum (Diamyd®), etanercept and vitamin D in children and adolescents newly diagnosed with type 1 diabetesewly diagnosed Type 1 diabetes (within 100 days)MedDRA version: 17.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-001323-76-SEinköping University20
尚未招募
Unknown
Evaluating uptake, engagement and effects of the Partners in Parenting (PiP) online parenting program, for adult carers of adolescents (12-18), delivered via headspace National Youth Mental Health Foundation.Adolescent depressionACTRN12623000642684Monash University500
已完成
不适用
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin.Chronic hepatitisC patients and compensated cirrhosis patientsJPRN-UMIN000008342Saitama Medical University80
已完成
不适用
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (>= 5 Log IU/mL)JPRN-UMIN000004210Saitama Medical University40